These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 1922221

  • 1. Allogeneic bone marrow transplantation in multiple myeloma. European Group for Bone Marrow Transplantation.
    Gahrton G, Tura S, Ljungman P, Belanger C, Brandt L, Cavo M, Facon T, Granena A, Gore M, Gratwohl A.
    N Engl J Med; 1991 Oct 31; 325(18):1267-73. PubMed ID: 1922221
    [Abstract] [Full Text] [Related]

  • 2. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia.
    Kersey JH, Weisdorf D, Nesbit ME, LeBien TW, Woods WG, McGlave PB, Kim T, Vallera DA, Goldman AI, Bostrom B.
    N Engl J Med; 1987 Aug 20; 317(8):461-7. PubMed ID: 3302708
    [Abstract] [Full Text] [Related]

  • 3. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors.
    Ash RC, Casper JT, Chitambar CR, Hansen R, Bunin N, Truitt RL, Lawton C, Murray K, Hunter J, Baxter-Lowe LA.
    N Engl J Med; 1990 Feb 22; 322(8):485-94. PubMed ID: 2300120
    [Abstract] [Full Text] [Related]

  • 4. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.
    Zittoun RA, Mandelli F, Willemze R, de Witte T, Labar B, Resegotti L, Leoni F, Damasio E, Visani G, Papa G.
    N Engl J Med; 1995 Jan 26; 332(4):217-23. PubMed ID: 7808487
    [Abstract] [Full Text] [Related]

  • 5. Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation.
    Gahrton G, Svensson H, Björkstrand B, Apperley J, Carlson K, Cavo M, Ferrant A, Fouillard L, Gratecos N, Gratwohl A, Guilhot F, Lambertenghi Deliliers G, Ljungman P, Masszi T, Milligan DW, Powles RL, Reiffers J, Samson JD, Stoppa AM, Vernant JP, Volin L, Wallvik J.
    Bone Marrow Transplant; 1999 Oct 26; 24(7):741-5. PubMed ID: 10516677
    [Abstract] [Full Text] [Related]

  • 6. An update of prognostic factors for allogeneic bone marrow transplantation in multiple myeloma using matched sibling donors. European Group for Blood and Marrow Transplantation.
    Gahrton G, Tura S, Ljungman P, Bladé J, Cavo M, De Laurenzi A, Façon T, Gratwohl A, Michallet M, Nikoskelainen J.
    Stem Cells; 1995 Aug 26; 13 Suppl 2():122-5. PubMed ID: 8520500
    [Abstract] [Full Text] [Related]

  • 7. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
    Lemoli RM, Bandini G, Leopardi G, Rosti G, Bonini A, Fortuna A, Rondelli D, Mangianti S, Motta MR, Rizzi S, Tassi C, Cavo M, Remiddi C, Curti A, Conte R, Tura S.
    Haematologica; 1998 Jan 26; 83(1):48-55. PubMed ID: 9542323
    [Abstract] [Full Text] [Related]

  • 8. Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma.
    Giralt S, Aleman A, Anagnostopoulos A, Weber D, Khouri I, Anderlini P, Molldrem J, Ueno NT, Donato M, Korbling M, Gajewski J, Alexanian R, Champlin R.
    Bone Marrow Transplant; 2002 Sep 26; 30(6):367-73. PubMed ID: 12235521
    [Abstract] [Full Text] [Related]

  • 9. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr 26; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 10. Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma.
    Gahrton G, Iacobelli S, Bandini G, Björkstrand B, Corradini P, Crawley C, Hegenbart U, Morgan G, Kröger N, Schattenberg A, Schönland SO, Verdonck LF, Volin L, de Witte T, Niederwieser D, Myeloma Subcommittee of the EBMT.
    Haematologica; 2007 Nov 26; 92(11):1513-8. PubMed ID: 18024400
    [Abstract] [Full Text] [Related]

  • 11. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program.
    Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, Gajewski J, Hansen JA, Henslee-Downey J, McCullough J.
    N Engl J Med; 1993 Mar 04; 328(9):593-602. PubMed ID: 8429851
    [Abstract] [Full Text] [Related]

  • 12. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N, Le Deist F, Cant A, De Graeff-Meeders ER, Fasth A, Morgan G, Vellodi A, Hale G, Bujan W, Thomas C, Cavazzana-Calvo M, Wijdenes J, Fischer A.
    Pediatrics; 1996 Sep 04; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [Abstract] [Full Text] [Related]

  • 13. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission.
    Lee SH, Lee MH, Lee JH, Min YH, Lee KH, Cheong JW, Lee J, Park KW, Kang JH, Kim K, Kim WS, Jung CW, Choi SJ, Lee JH, Park K.
    Biol Blood Marrow Transplant; 2005 Feb 04; 11(2):122-8. PubMed ID: 15682073
    [Abstract] [Full Text] [Related]

  • 14. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
    Zakerinia M, Khojasteh HN, Ramzi M, Haghshenas M.
    Transplant Proc; 2005 Dec 04; 37(10):4477-81. PubMed ID: 16387149
    [Abstract] [Full Text] [Related]

  • 15. Long-term follow up of patients with multiple myeloma after high-dose chemotherapy and allogeneic stem cell transplantation.
    Rabitsch W, Prinz E, Ackermann J, Wöhrer S, Kaufmann H, Seidl S, Keil F, Kalhs P, Greinix H, Gisslinger H, Leitner G, Drach J.
    Eur J Haematol; 2004 Jan 04; 72(1):26-31. PubMed ID: 14962259
    [Abstract] [Full Text] [Related]

  • 16. Allogeneic bone marrow transplantation in multiple myeloma.
    Gahrton G.
    Pathol Biol (Paris); 1999 Feb 04; 47(2):188-91. PubMed ID: 10192887
    [Abstract] [Full Text] [Related]

  • 17. Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma.
    Reynolds C, Ratanatharathorn V, Adams P, Braun T, Silver S, Ayash L, Carson E, Eisbruch A, Dawson LA, McDonagh K, Ferrara J, Uberti J.
    Bone Marrow Transplant; 2001 Apr 04; 27(8):801-7. PubMed ID: 11477436
    [Abstract] [Full Text] [Related]

  • 18. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
    Badell I, Ortega JJ, Muñoz A, Bureo E, Madero L, Olivé T, Cubells J, Maldonado MS, Baro J, Díaz MA.
    Sangre (Barc); 1996 Apr 04; 41(2):101-8. PubMed ID: 9045349
    [Abstract] [Full Text] [Related]

  • 19. Engraftment of HLA-matched sibling hematopoietic stem cells after immunosuppressive conditioning regimen in patients with hematologic neoplasias.
    Carella AM, Lerma E, Dejana A, Corsetti MT, Celesti L, Bruni R, Benvenuto F, Figari O, Parodi C, Carlier P, Florio G, Lercari G, Valbonesi M, Casarino L, De Stefano F, Geniram A, Venturino M, Tedeschi L, Palmieri G, Piaggio G, Podestà M, Frassoni F, Van Lint MT, Marmont AM, Bacigalupo A.
    Haematologica; 1998 Oct 04; 83(10):904-9. PubMed ID: 9830799
    [Abstract] [Full Text] [Related]

  • 20. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.
    Bensinger WI, Martin PJ, Storer B, Clift R, Forman SJ, Negrin R, Kashyap A, Flowers ME, Lilleby K, Chauncey TR, Storb R, Appelbaum FR.
    N Engl J Med; 2001 Jan 18; 344(3):175-81. PubMed ID: 11172139
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.